InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.42
(
0.48%
)
Bitcoin
62,634.01
(
-0.83%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

guardiangel

Send PM Follow Ignore
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

guardiangel

Re: guardiangel post# 20829

Thursday, 04/17/2014 9:20:58 AM

Thursday, April 17, 2014 9:20:58 AM

Post# of 30046
The Wolf Says

"The rationale for the merger is that PDI has all rights, patents and trademarks for diagnostic technologies that Radient Pharmaceuticals believes will strengthen and complement its core business. Pursuant to the LOI, Provista will become a wholly-owned subsidiary of Radient Pharmaceuticals."

Columbo Says


Who has all the recent patents, trademarks,ect...Provista Diagnostics DX. THERE IS YOUR PATENTS GENTLEMEN...Not too late to BUY you understand...Wolf
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up